SeromaNCT07918430
Primary Sac Abandonment and Distal Sac Fixation vs Complete Sac Dissection for Inguinoscrotal Hernias
A study testing Primary abondonment of sac and distal sac fixation and complete sac dissection in people with Seroma and Inguinal Hernias, run by Kasr El Aini Hospital at 1 site in Egypt.
Trial summary
The goal of this clinical trial is to compare the effect of primary abandonment of the sac and distal sac fixation vs complete sac dissection in patients with inguinoscrotal hernias undergoing trans abdominal pre-peritoneal (TAPP) procedure. The main questions it aims to answer are: 1. Read more about this study
- Who is it for?
- Ages 18 years and older, men onlyHealthy volunteers can take part
- Conditions the study is for
- Seroma, Inguinal Hernias
- What is being tested?
- Primary abondonment of sac and distal sac fixation and complete sac dissection
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Nov 2026to 1 Oct 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- inguinoscrotal hernias
Who cannot join
- Strangulated hernias
- Recurrent inguinal hernias
- Patients unfit for general anaesthesia and laparoscopy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Kasr Alainy
Cairo
Tarek Salem Mabrouk, 00201143307034, tareksalem2018011@gmail.com
About this study
The goal of this clinical trial is to compare the effect of primary abandonment of the sac and distal sac fixation vs complete sac dissection in patients with inguinoscrotal hernias undergoing trans abdominal pre-peritoneal (TAPP) procedure. The main questions it aims to answer are:
- The incidence of post-operative seroma.
- Difference in operative time
- Short-term hernia recurrence
- Conditions
- Seroma, Inguinal Hernias
- Being tested
- Primary abondonment of sac and distal sac fixation, complete sac dissection
- Keywords
- inguinoscrotal hernia, TAPP, Seroma, Distal sac fixation
- Medical subject headings
- Seroma, Hernia, Inguinal
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Primary abondonment of sac and distal sac fixationProcedure or surgery
Primary abondonment of sac and distal sac fixation
complete sac dissectionProcedure or surgery
complete sac dissection
| Study group | Role | What they receive |
|---|---|---|
| Primary sac abandonment and distal sac fixation | Experimental | Not described Receives: Procedure: Primary abondonment of sac and distal sac fixation |
| Complete sac dissection | Active comparator | Not described Receives: Procedure: complete sac dissection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Seroma
Post-operative scrotal collection
Measured: 30 days post-operatively
Secondary outcomes (2)
Operative time
Measured: Skin to skin operative time of the procedure
Short term hernia recurrence
Measured: hernia recurrence 3 months after the procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2026
- Study start1 Nov 2026 (estimated)
- Primary completion1 Aug 2027 (estimated)
- Study completion1 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SeromaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kasr El Aini Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ayman Alayat, Kasr El Aini Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07918430
- Sponsor's protocol ID
- MS-383_2026
- Status last verified
- Oct 2026
- First submitted
- 30 Oct 2026
- Last updated
- 5 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Primary Sac Abandonment and Distal Sac Fixation vs Complete Sac Dissection for Inguinoscrotal Hernias
- ClinicalTrials.gov ID
- NCT07918430
- Acronym / sponsor ID
- MS-383_2026
- Conditions
- Seroma, Inguinal Hernias
- Keywords
- inguinoscrotal hernia, TAPP, Seroma, Distal sac fixation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Kasr El Aini HospitalUniversity, hospital or other
- Study start
- 1 Nov 2026 (estimated)
- Primary completion
- 1 Aug 2027 (estimated)
- Study completion
- 1 Oct 2027 (estimated)
- First posted
- 5 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to compare the effect of primary abandonment of the sac and distal sac fixation vs complete sac dissection in patients with inguinoscrotal hernias undergoing trans abdominal pre-peritoneal (TAPP) procedure. The main questions it aims to answer are:
- The incidence of post-operative seroma.
- Difference in operative time
- Short-term hernia recurrence
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Primary sac abandonment and distal sac fixation | Experimental | Procedure: Primary abondonment of sac and distal sac fixation |
| Complete sac dissection | Active comparator | Procedure: complete sac dissection |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- inguinoscrotal hernias
Key exclusion criteria (3 listed)
- Strangulated hernias
- Recurrent inguinal hernias
- Patients unfit for general anaesthesia and laparoscopy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Primary abondonment of sac and distal sac fixationPrimary abondonment of sac and distal sac fixation | Procedure or surgery | Primary sac abandonment and distal sac fixation |
| complete sac dissectioncomplete sac dissection | Procedure or surgery | Complete sac dissection |
Primary outcome
Seroma
Time frame: 30 days post-operatively
Post-operative scrotal collection
2 secondary outcomes
Operative time
Time frame: Skin to skin operative time of the procedure
Short term hernia recurrence
Time frame: hernia recurrence 3 months after the procedure
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2026.
Related trials for Seroma
Recruiting
Comparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair
Indirect Inguinal Hernia
Not yet recruiting
Topical Tranexamic Acid Spray Versus No Spray on Postoperative Outcomes Following Mesh Repair of Umbilical Hernia
Umbilical Hernia Repair
Recruiting
Hernia Sac Flap Coverage of Mesh in Bony-Edged Ventral Hernia Repair
Incisional Hernia, Abdominal Hernia
RecruitingPhase 4
The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery
Surgical Complication
Recruiting
Effects of Negative Pressure Wound Bandaging After Mastectomy
Breast Cancer - Female
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Primary abondonment of sac and distal sac fixation and complete sac dissection in people with Seroma and Inguinal Hernias, run by Kasr El Aini Hospital at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Tarek Salem Mabrouk (00201143307034, tareksalem2018011@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Seroma (time frame: 30 days post-operatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.